Effect of Nifedipine and Enalapril on Insulin-Induced Glucose Disposal in Spontaneous Hypertensive and Diabetic Rats

References

• Modan M., Halkin H., Almog S. Hyperinsulinaemia: A link between hypertension obesity and glucose intolerance. J Clin Invest 1985; 75: 809–17
   PubMed Web of Science ®Google Scholar
• Marigliano A., Tedde R., Sechi L. A., Pala A., Pisanu G., Pacifico A. Insulinemia and blood pressure: relationships in patients with primary and secondary hypertension and with or without glucose metabolism impairment. Am J Hypertens. 1990; 3: 521–526
   PubMed Web of Science ®Google Scholar
• Frontoni S., Ohman L., Haywood J. R., Rossetti L. Increased insulin sensitivity in the high sodium one-kidney one figure-8 hypertensive rat In vivo insulin action in genetic models of hypertension. Hypertension 1992; 20: 192–198
   PubMed Web of Science ®Google Scholar
• Ferrannini E., DeFronzo R. A. Insulin actions in vivo: glucose metabolism. International Textbook of Diabetes Mellitus, K.G.M.M. Alberti, R.A. Defronzo, H. Keen, P. Zimmet. John Wiley, Chichester 1992; 409–438
   Google Scholar
• Feher M. D., Rampling M. W., Sever P. S., Elkeles R. S. Diabetic hypertension - the importance of fibrinogen and blood viscosity. J Hum Hypertension; 1988; 2: 117–122
   PubMed Web of Science ®Google Scholar
• Pollare T., Lithell H., Berne C. Insulin resistance is a characteristic feature of primary hypertension independent of obesity. Metabolism 1990; 39: 167–174
   PubMed Web of Science ®Google Scholar
• Ferrannini E., Buzzigoli G., Bonadonna R., et al. Insulin resistance in essential hypertension. N Engl J Med. 1987; 317: 350–357
   PubMed Web of Science ®Google Scholar
• Mondon C. E., Reaven G. M. Evidence of abnormalities of insulin metabolism in rats with spontaneous hypertension. Metabolism 1988; 37: 303–305
   PubMed Web of Science ®Google Scholar
• Hulman S., Falkner B., Freyvogel N. Insulin resistance in the conscious spontaneously hypertensive rat: euglycemic hyperinsulinaemic clamp study. Metabolism 1993; 42: 14–18
   PubMed Web of Science ®Google Scholar
• Buchanan T. A., Sipos G. F., Madrilejo N., Liu C., Campese V. M. Hypertension without peripheral insulin resistance in spontaneously hypertensive rats. Am J Physiol. 1992; 262: E14–E19
   Google Scholar
• Revan G. M., Hoffman B. B. Hypertension as a disease of carbohydrates and lipoprotein metabolism. Am J Med. 1989; 87(6A)2
   PubMedGoogle Scholar
• Kahn C. R., Saad M. J.A. Alterations in insulin receptor and substrate phosphorylation in hypertensive rats. J Am Soc Nephrol. 1992; 3: S69–S77
   Google Scholar
• Parulekar A., Hakim Z. S., Santani D. D., Goyal R. K. Effect of chronic treatment with spirapril on biochemical parameters in streptozotocin diabetic and spontaneously hypertensive rats. Ind J Expt Biol. 1997; 35: 1182–1186
   PubMedGoogle Scholar
• Srinvas P. S., Hakim Z. S., Santani D. D., Goyal R. K. Effect of chronic treatment with amlodipine in streptozotocin diabetic and spontaneously hypertensive rats. Pharm Res. 1997; 35: 423–428
   Google Scholar
• Shah T. S., Satia M. C., Gandhi T. P., Bangaru A., Goyal R. K. Effect of chronic treatment with nifedipine on streptozotocin-induced diabetic rats. J Cardiovasc Pharmacol. 1995; 26: 6–12
   PubMed Web of Science ®Google Scholar
• Alford P. P., Martin F. I.R., Pearson M. J. The significance and interpretation of mildly abnormal oral glucose tolerance. Diabetdogia 1971; 7: 173–180
   PubMed Web of Science ®Google Scholar
• Lundbaek K. Intravenous glucose tolerance as a tool in definition and diagnosis of diabetes mellitus. Br Med J. 1962; 1: 1507–1513
   PubMed Web of Science ®Google Scholar
• Bao W., Sathanur R. S., Wattigney A. W., et al. Persistence of multiple cardiovascular risk clusterin related to syndrome X. from childhood to young adulthood. Arch Intern Med. 1994; 154: 1842–1847
   PubMed Web of Science ®Google Scholar
• Grulet H., Durlach V., Hecart A. C., Gross A., Leutenegger M. Study of the rate of early glucose disappearance following insulin injection: insulin sensitivity index. Diabetes Res Clin Pract. 1993; 20: 201–207
   PubMed Web of Science ®Google Scholar
• Croog S. H., Levine S., Testa M. A., Brown B., Bulpitt C. J. The effects of antihypertensive therapy on the quality of life. Nifedipine Eng J Med. 1986; 314: 1657–1664
   PubMed Web of Science ®Google Scholar
• Bondi A., Ciofalo G. Effectiveness tolerance and long term compliance with nifedipine slow release in hypertensive patients with concomitant and severe pathologies. Cur Ther Res. 1988; 43: 815–823
   Web of Science ®Google Scholar
• Parent R., Chiasson J. L., Larochelle P. Hemodynamic and endocrine effects of acute and chronic administration of nifedipine. J Clin Pharmacol. 1989; 29: 59–64
   PubMed Web of Science ®Google Scholar
• Weber M. A., Neutel J. M., Smith D. H.G. Circulatory and extracirculatory effects of angiotensin-converting enzyme. Am Heart J. 1992; 123: 1414–1420
   PubMed Web of Science ®Google Scholar
• Rett K., M Wicklmayr., Tschollar G., Dietz G., Mehnert H. Role of angiotensin converting enzyme inhibitors in early antihypertensive treatment in non-insulin dependent diabetes mellitus. Postgraduate Med J. 1988; 64(Suppl. 3)69–73
   PubMedGoogle Scholar
• Jauch K. W., Hartl W., Guenther B., Wicklmayr M., Rett K. Captopril enhances insulin responsiveness of forearm muscle tissue in non-insulin dependant diabetes mellitus. Eur J Clin Invest. 1987; 17: 448–454
   PubMed Web of Science ®Google Scholar
• Torlone E., Rambotti A. M., Perriello G., Botta G., Santeusanio E. ACE inhibition increases hepatic and extrahepatic sensitivity to insulin in patients with Type-II (non insulin dependant) diabetes mellitus and arterial hypertension. Diabetologia 1991; 34: 119–125
   PubMed Web of Science ®Google Scholar
• Pollare T., Lithell H., Berne C. A comparison of the effects of hydrochlorothiazide and captotpril on glucose and lipid metabolism in patients with hypertension. Nifedipine Eng J Med. 1989; 321: 868–873
   PubMed Web of Science ®Google Scholar